Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience

Francesco Autore; Idanna Innocenti; Francesca Morelli; Federica Sora'; Andrea Corbingi; Luana Fianchi; Marianna Criscuolo; Livio Pagano; Simona Sica; Luca Laurenti

doi:10.1002/hon.2623

Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience

Francesco Autore, Idanna Innocenti, Francesca Morelli, Federica Sora', Andrea Corbingi, Luana Fianchi, Marianna Criscuolo, Livio Pagano, Simona Sica, Luca Laurenti

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

n/a

Lingua originale	English
pagine (da-a)	496-497
Numero di pagine	2
Rivista	Hematological Oncology
Volume	37
DOI	https://doi.org/10.1002/hon.2623
Stato di pubblicazione	Pubblicato - 2019

Keywords

Ibrutinib
Idelalisib
chronic lymphocytic leukemia
infections

Accesso al documento

10.1002/hon.2623

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{909c64b8422e48e5a9377ecda03b0598,

title = "Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience",

abstract = "n/a",

keywords = "Ibrutinib, Idelalisib, chronic lymphocytic leukemia, infections, Ibrutinib, Idelalisib, chronic lymphocytic leukemia, infections",

author = "Francesco Autore and Idanna Innocenti and Francesca Morelli and Federica Sora' and Andrea Corbingi and Luana Fianchi and Marianna Criscuolo and Livio Pagano and Simona Sica and Luca Laurenti",

year = "2019",

doi = "10.1002/hon.2623",

language = "English",

volume = "37",

pages = "496--497",

journal = "Hematological Oncology",

issn = "1099-1069",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience

AU - Autore, Francesco

AU - Innocenti, Idanna

AU - Morelli, Francesca

AU - Sora', Federica

AU - Corbingi, Andrea

AU - Fianchi, Luana

AU - Criscuolo, Marianna

AU - Pagano, Livio

AU - Sica, Simona

AU - Laurenti, Luca

PY - 2019

Y1 - 2019

N2 - n/a

AB - n/a

KW - Ibrutinib

KW - Idelalisib

KW - chronic lymphocytic leukemia

KW - infections

KW - Ibrutinib

KW - Idelalisib

KW - chronic lymphocytic leukemia

KW - infections

UR - http://hdl.handle.net/10807/135451

U2 - 10.1002/hon.2623

DO - 10.1002/hon.2623

M3 - Article

SN - 1099-1069

VL - 37

SP - 496

EP - 497

JO - Hematological Oncology

JF - Hematological Oncology

ER -

Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo